UK markets close in 1 hour 20 minutes

HCA Healthcare, Inc. (HCA.MX)

Mexico - Mexico Delayed price. Currency in MXN
Add to watchlist
5,200.000.00 (0.00%)
As of 12:33PM CST. Market open.
Currency in MXN

Valuation measures4

Market cap (intra-day) 1.51T
Enterprise value 2.21T
Trailing P/E 15.23
Forward P/E 14.88
PEG ratio (5-yr expected) 1.36
Price/sales (ttm)1.25
Price/book (mrq)N/A
Enterprise value/revenue 1.95
Enterprise value/EBITDA 9.90

Trading information

Stock price history

Beta (5Y monthly) 1.67
52-week change 310.15%
S&P500 52-week change 323.49%
52-week high 35,475.92
52-week low 34,032.82
50-day moving average 35,350.12
200-day moving average 34,822.94

Share statistics

Avg vol (3-month) 3147
Avg vol (10-day) 38
Shares outstanding 5261.91M
Implied shares outstanding 6291.34M
Float 8188.7M
% held by insiders 127.48%
% held by institutions 164.15%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 445.43
Forward annual dividend yield 40.87%
Trailing annual dividend rate 32.46
Trailing annual dividend yield 30.05%
5-year average dividend yield 4N/A
Payout ratio 412.27%
Dividend date 3N/A
Ex-dividend date 414 Jun 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 8.20%
Operating margin (ttm)14.76%

Management effectiveness

Return on assets (ttm)11.12%
Return on equity (ttm)845.54%

Income statement

Revenue (ttm)66.72B
Revenue per share (ttm)247.75
Quarterly revenue growth (yoy)11.20%
Gross profit (ttm)N/A
EBITDA 12.87B
Net income avi to common (ttm)5.47B
Diluted EPS (ttm)341.12
Quarterly earnings growth (yoy)16.70%

Balance sheet

Total cash (mrq)1.38B
Total cash per share (mrq)5.26
Total debt (mrq)42.1B
Total debt/equity (mrq)3,315.20%
Current ratio (mrq)1.16
Book value per share (mrq)-6.14

Cash flow statement

Operating cash flow (ttm)10.1B
Levered free cash flow (ttm)3.78B